An Alternative Device for the Topical Treatment of Oral Cancer: Development and Ex-Vivo Evaluation of Imiquimod-Loaded Polysaccharides Formulations

An Alternative Device for the Topical Treatment of Oral Cancer: Development and Ex-Vivo Evaluation of Imiquimod-Loaded Polysaccharides Formulations

The topical use of imiquimod (IMQ), a non-specific immune response modifier, showed to be a promising therapeutic option for the early-stage treatment of some type of oral cancer, even when performed with a formulation (Aldara<sup>®</sup>) developed and approved for skin application. The...

Full description

Bibliographic Details
Main Authors: Paula de Freitas Rosa Remiro, Mariana Harue Taniguchi Nagahara, Martina Ghezzi, Alessia Filippini, Anna Demurtas, Silvia Pescina, Patrizia Santi, Cristina Padula, Ângela Maria Moraes, Sara Nicoli
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmaceutics
Subjects:
imiquimod
oral cancer
buccal delivery
hydrogel
alginate
xanthan gum
Online Access:https://www.mdpi.com/1999-4923/14/12/2573

Internet

https://www.mdpi.com/1999-4923/14/12/2573

Similar Items